Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Alberto A. Gabizon, Hadar Goldvaser et al. - Unknown
Supplement Figure S-12 from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Alberto A. Gabizon, Hadar Goldvaser et al. - Unknown